MedTrace Logo

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

NCT05442151 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-07-31

No results posted yet for this study

Summary

PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.

Conditions

  • Neoplasms

Interventions

DRUG

PET/CT ([F-18]FAPI-74)

PET/CT using \[18F\] FAPI-74 injection

Sponsors & Collaborators

  • Tadashi Watabe

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442151 on ClinicalTrials.gov